Type 2 diabetes
Conditions
Interventions
Observation group:None
Sponsors
The Second Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old <=age <= 80 years old; 2. Diagnosed with type 2 diabetes mellitus according to WHO diagnostic criteria, currently receiving or eligible for add-on therapy with Henggliflozin; 3. Voluntarily participate in this study and sign the informed consent form. If the subject does not have the ability to read the informed consent form (e.g., illiterate subjects), a witness is required to witness the informed process and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Participation in or current enrollment in clinical trials investigating other glucose-lowering medications within 1 month prior to the initiation of this study; 2. Current or history of recurrent urinary tract infections (UTIs) and/or genital infections; 3. Patients judged by the investigator to be unsuitable to participate in this clinical trial, with considerations such as current blood volume status, estimated glomerular filtration rate (eGFR), and other clinical parameters.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Events or Serious Adverse Events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin;Fasting Plasma glucose;Plasma glucose 2 hours postprandial;Blood Pressure;weight;Specific adverse events; | — |
Countries
China
Contacts
Public ContactLiang Yuzhen
The Second Affiliated Hospital of Guangxi Medical University
Outcome results
None listed